RE: Forward Look Newsflow11 Nov 2020 21:53
Hi S4
For me as a fairly recent holder, what sparked my interest was the very low mcap and when I researched it I came across the contrast free imaging.
I bought in straight away and then we had the rns dated 30 October.
Imo opinion if the Gad free imaging is validated the share price will explode
There have been subsequent rns notices which have been very positive and the link that Clair posted is great research, once these are approved by the FDA they all ad up to make iqai a very good investment.
AS of now this is a very exciting company to be involved with
I have a substantial number of shares and there is no way these will be sold in the short term
ALB